Assistant Professor Peter Sims and postdoctoral research scientist Jinzhou Yuan displaying their platform for automated single-cell RNA sequencing. (Photo: Lynn Saville)
Assistant Professor Peter Sims, PhD , has been awarded an inaugural Chan Zuckerberg Initiative (CZI) award for gene sequencing research that will help advance the Human Cell Atlas project. Launched in 2016 by a cohort of world-leading scientists, the Human Cell Atlas is a high-profile endeavor whose goal is to identify and define every cell type of the human body and create a collection of maps that will describe the cellular basis of health and disease.
With the support of CZI, founded by Facebook CEO Mark Zuckerberg and his wife, Priscilla Chan, Dr. Sims and his group in the Department of Systems Biology will receive grant funding to pilot a revolutionary technique for high throughput single-cell sequencing. Called SCOPE-Seq, the novel, economical method conducts RNA sequencing coupled with live imaging of the same individual cell on a large scale.
“We hope that our approach will provide functional insights into the novel cell types that will be discovered by the Human Cell Atlas effort that cannot be obtained from genomic analysis alone,” said Dr. Sims.
Fellow Systems Biology Professor Raul Rabadan, PhD , who directs the Center for Topology of Cancer Evolution and Heterogeneity, also is gaining support from CZI in a collaboration led by Tom Maniatis, PhD, who won the grant for their research to construct an atlas of gene activity of all cells in the human spinal cord. Dr. Maniatis chairs the Department of Biochemistry and Molecular Biophysics, directs Columbia's Precision Medicine Initiative and is a principal investigator at Columbia's Mortimer B. Zuckerman Mind Brain Behavior Institute.